Palatin Technologies Inc. (PTN)

[Agreed]

Earnings are not really the story at this time. We’re waiting to hear from FDA (before end of May?) whether NDA application is sufficient and will have a date by which it expects to complete review. If positive news, stock will react very positively. We’re also waiting for new deals to be announced, those could happen before an FDA application acceptance, but would think definitely after as companies will want to be on board for potential approval.

Bottom line is, news we’re waiting for will cause monumental movements up or down, positive or negative. If you’re optimistic, however, I would not risk selling this stock.